May 11, 2022 — Vital Heart & Vein, a leading provider of cardiovascular and vein health, has named Gay Nord as its new chief executive officer. 

In her new role, she will oversee operations of Vital Heart & Vein's current and future locations and spearhead the organization's growth and development. 

Back on track after its in-person hiatus, ACC22 stressed industry resilience, and featured practice-changing science and innovations

In April, the cardiology community converged face-to-face in Orlando for The American College of Cardiology’s (ACC22) Annual Scientific Session after a two-year hiatus that forced the conference to go virtual due to the ongoing

May 10, 2022 — The MIVI Neuroscience Q Aspiration Catheter incorporates a novel pusher wire design on its proximal end. This feature has demonstrated in simulated use studies that the Q Catheter may be uniquely suited to allow physicians in the future to treat ischemic stroke patients remotely via a robot from a different room, a different city, or even a different country. 

May 10, 2022 — MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology market, today announced that Butterfly Network, Inc., a digital health company transforming care with handheld, whole-body ultrasound, has been selected as the winner of the “Best New Ultrasound Solution” award in the si

May 10, 2022 — After two years of virtual meetings, the Society for Cardiovascular Angiography & Interventions (SCAI) looks forward to welcoming more than 2,000 attendees to an exciting, fully live meeting in Atlanta, May 19-22.

May 10, 2022 — Faraday Pharmaceuticals, Inc., today announced the enrollment of the first patient in its Iocyte AMI-3 study — a Phase 3 clinical trial assessing the efficacy and safety of FDY-5301 in reducing cardiovascular (CV) death and heart failure in anterior ST-segment elevation myocardial infarction (

May 9, 2022 — Heart failure presents differently in women and men – discover the latest evidence and its impact on management at

Primary tabs View(active tab) Edit Delete Revisions Entityqueue Devel Open configuration options Open configuration options Videos | Venous Therapies | June 27, 2017 VIDEO: How the Ekos Thrombolytic Technology Works to Dissolve Clots Open Related Chest Pain Imaging Content: configuration options Venous Thrombolytic System Demonstration Play Mute Remaining Time -3:23 Picture-in-Picture Fullscreen This video, provided by Ekos, demonstrates the EkoSonic endovascular System thrombolytic system to treat dee

Here are the top 10 performing videos on the Diagnostic and Interventional Cardiology (DAIC) website during the month of April. The picks are based on Google Analytics of the DAIC website's video pageviews for the month, showing the top viewed content.

1. VIDEO: How the Ekos Thrombolytic Technology Works to Dissolve Clots

May 9, 2022 — CVRx, Inc., developer of the world’s first FDA-approved neuromodulation device to treat the symptoms of heart failure, has received U.S.

COVID-19 had a profound impact on the cardiovascular imaging system in 2020.

The global cardiovascular ultrasound systems market was expected to register a CAGR of 5.9% over the forecast period, according to The Cardiovascular Ultrasound System Market—Growth, Trends, COVID-19 Impact and Forecast (2022-2027), a new report f
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now